The need for novel approaches in assessing the value of COVID-19 vaccines

Angelis, A.ORCID logo, Baltussen, R. & Tervonen, T. (2021). The need for novel approaches in assessing the value of COVID-19 vaccines. American Journal of Public Health, 111(2), 205 - 208. https://doi.org/10.2105/AJPH.2020.306066
Copy

Numerous Covid-19 vaccine development programs are under way and several vaccines with potentially differing clinical and manufacturing profiles are expected to reach the market. We argue for the need to adopt new approaches for assessing the value of Covid-19 vaccines, calling for clinical, manufacturing and cost aspects to be complemented by societal value considerations to inform the vaccines’ development, reimbursement and pricing decisions.
Item Type Article
Copyright holders © 2021 American Public Health Association
Departments LSE > Academic Departments > Health Policy
LSE > Research Centres > LSE Health
DOI 10.2105/AJPH.2020.306066
Date Deposited 14 Jan 2021
Acceptance Date 15 Nov 2020
URI https://researchonline.lse.ac.uk/id/eprint/108415

Explore Further

Full text not available from this repository.

Export as

EndNote BibTeX Reference Manager Refer Atom Dublin Core JSON Multiline CSV
Export

Downloads
View more statistics